Shots: Halozyme to receive $30M upfront, $160M milestones, $10M per future target nominations and royalties on sales of products. Argenx to get an exclusive license for Halozyme’s ENHANZE technology targeting […]readmore
Tags : Agreement
Shots: Bayer and Kyoto University collaborate to jointly conduct clinical trials for identifying targets in lung diseases. Bayer will have an exclusive option to license the developed product in the […]readmore
Shots: Janssen to get exclusive WW license rights to develop & commercialize certain clinical candidates in MeiraGTx’s inherited retinal disease pipeline. Janssen also has an option to license the portfolio […]readmore
Shots: Alivio to receive $14.75M upfront, $260M milestones, license exercise payments and royalties on sales of product from Purdue. Purdue to get an option to add more compounds to the […]readmore
Shots: Merck KGaA to receive upfront, milestones, and royalties on net sales. Vertex to get exclusive license rights for Merck’s two DNA-dependent protein kinase (DNA-PK) inhibitors, M9831 (formerly known as […]readmore
Shots: Rigel to receive $30M upfront, $297.5M milestones including $20M on EMA approval of fostamatinib and royalties up to 30% on net sales. Grifols to get exclusive rights for fostamatinib […]readmore
Shots: The companies collaborated to develop gene-modified NK Cell therapies using CARs (Chimeric antigen receptor) and TCRs (T cell receptors) in the fields of oncology The focus of the agreement […]readmore
Shots: Klaria to receive $55.2M as total deal value, including $5.2M as near-term milestones and royalties on sales from Purdue. Purdue to get exclusive license rights to develop & commercialize […]readmore
Shots: AstraZeneca to get exclusive promotion rights in China including Taiwan, Hong Kong, Singapore, Malaysia for Luye’s Xuezhikang capsules. Luye Pharma will retain its IPR, commercialization rights, asset rights & […]readmore
Shots: Cipla to get exclusive commercialization rights for Bio-Thera’s BAT1706 in certain countries. Bio-Thera will be responsible for its development & product approval with FDA & EMA In 2020, Bio-Thera […]readmore